Hyperhidrosis, characterized by excess sweat production, affects children and adults. Primary focal hyperhidrosis affects any anatomic region with sweat appendages present. Primary hyperhidrosis has traditionally been considered a problem for adults, but approximately 1.6% of adolescents and 0.6% of prepubertal children are affected. Psychological and social development and well-being are often affected, leading to profound emotional and social distress. Quality of life can be improved by early diagnosis and therapy; however, underdiagnosis and lack of knowledge regarding therapeutic options has hindered optimization of therapy in the pediatric population. This article reviews the treatment options for hyperhidrosis with a focus on the pediatric population.
Keywords: Botulinum toxin; Hyperhidrosis; Iontophoresis; Pediatric population.
Copyright © 2014 Elsevier Inc. All rights reserved.